Skip to main content
logo
Lupin Limited (BOM:500257)
India flag India · Delayed Price · Currency is INR
2,165.05
+25.65 (1.20%)
At close: Jan 22, 2026

Lupin Revenue

Lupin had revenue of 70.48B INR in the quarter ending September 30, 2025, with 24.23% growth. This brings the company's revenue in the last twelve months to 247.51B, up 15.49% year-over-year. In the fiscal year ending March 31, 2025, Lupin had annual revenue of 227.08B with 13.48% growth.

Revenue (ttm)
247.51B
Revenue Growth
+15.49%
P/S Ratio
3.94
Revenue / Employee
10.31M
Employees
24,006
Market Cap
976.25B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025227.08B26.97B13.48%
Mar 31, 2024200.11B33.69B20.25%
Mar 31, 2023166.42B2.36B1.44%
Mar 31, 2022164.05B12.43B8.19%
Mar 31, 2021151.63B-2.12B-1.38%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Dr. Reddy's Laboratories342.15B
Torrent Pharmaceuticals122.48B
Jubilant Pharmova76.18B
Abbott India67.14B
Granules India48.42B
J. B. Chemicals & Pharmaceuticals41.93B
GlaxoSmithKline Pharmaceuticals37.09B
Caplin Point Laboratories20.42B
Revenue Rankings

Lupin News

More News